These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 200016)

  • 1. [Study of the vaccinating properties of 2 variants of Marek's disease virus].
    Iakovleva LS; Merekalova ZI; Pavlovskaia AI; Plakhov IV; Mazurenko NP
    Vopr Virusol; 1977; (4):493-6. PubMed ID: 200016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of postvaccinal immunity in Marek's disease].
    Iakovleva LS; Mazurenko NP
    Vopr Virusol; 1977; (3):331-6. PubMed ID: 198968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notes on the mechanism of postvaccination immunity in Marek's disease.
    Yakovleva LS; Mazurenko NP
    Neoplasma; 1977; 24(4):387-94. PubMed ID: 198688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative antigenic characteristics of 2 Marek's disease virus variants and of herpesvirus of turkeys isolated in the USSR].
    Zueva IuN; Iakovleva LS; Tsvetkov VS; Lavrov SV; Mazurenko NP
    Vopr Virusol; 1976; (5):614-9. PubMed ID: 64031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccinating properties of the Kekava 55 strain of attenuated Marek's disease virus].
    Iakovleva LS; Mazurenko NP
    Vopr Virusol; 1983; 28(6):689-93. PubMed ID: 6322454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marek's disease virus (Kekava strain) replication in chickens, chick embryos and cell cultures.
    Yakovleva LS; Mazurenko NP; Gunenkova NK; Vinogradov VN; Pavlovskaya AI; Chernyakhovskaya IY
    Acta Virol; 1975 Jul; 19(4):293-8. PubMed ID: 241226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early posthatch protection against Marek's disease in chickens vaccinated in ovo with a CVI988 serotype 1 vaccine.
    Zhang Y; Sharma JM
    Avian Dis; 2001; 45(3):639-45. PubMed ID: 11569737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marek's disease--the disease and its prevention by vaccination.
    Biggs PM
    Br J Cancer Suppl; 1975 Mar; 2():152-5. PubMed ID: 170953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of Marek's disease vaccine.
    Ben-Nathan D; Lustig S
    Adv Biotechnol Processes; 1990; 14():347-65. PubMed ID: 2171556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of cell-associated vaccines against Marek's disease virus grown in QT35 cells or JBJ-1 cells.
    Geerligs H; Spijkers I; Rodenberg J
    Avian Dis; 2013 Jun; 57(2 Suppl):448-53. PubMed ID: 23901760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
    Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
    Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection.
    Jarosinski KW; Yunis R; O'Connell PH; Markowski-Grimsrud CJ; Schat KA
    Avian Dis; 2002; 46(3):636-49. PubMed ID: 12243528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.